Diabetes mellitus a hepatitida C

HUSA, Petr and Petr HUSA. Diabetes mellitus a hepatitida C (Diabetes mellitus and hepatitis C). Forum diabetologicum. Brno: Facta Medica, 2016, vol. 5, No 3, p. 134-136. ISSN 1805-3807.

Basic information

Original name

Diabetes mellitus a hepatitida C

Name (in English)

Diabetes mellitus and hepatitis C

Authors

HUSA, Petr (203 Czech Republic, belonging to the institution) and Petr HUSA (203 Czech Republic, guarantor, belonging to the institution)

Edition

Forum diabetologicum, Brno, Facta Medica, 2016, 1805-3807

---

Other information

Language

Czech

Type of outcome

Article in a journal

Field of Study

30300 3.3 Health sciences

Country of publisher

Czech Republic

Confidentiality degree

is not subject to a state or trade secret

RIV identification code

RIV/00216224:14110/16:00092645

Organization unit

Faculty of Medicine

Keywords (in Czech)

extrahepatální manifestace; chronická hepatitida C; přímo působící virostatika

Keywords in English

extrahepatic manifestations; chronic hepatitis C; direct acting antivirals

Tags

EL OK

Tags

Reviewed

---

Abstract

In the original language

Extrahepatální projevy infekce virem hepatitidy C (HCV) jsou velmi časté. Souvislost s infekcí HCV je považována za prokázanou i u membranoproliferativní glomerulonefritidy, leukocytoklastické vaskulitidy, lymfoproliferativ-ních onemocnění (zejména B-buněčného lymfomu), Sjógrenova a sicca syndromu, lichen planus, porfyria cuta-nea tarda a diabetes mellitus. Antivirová terapie chronické infekce HCV může zabránit progresi do diabetů u pacientů s prediabetem a redukovat nebezpečí vzniku renálních a kardiovaskulárních komplikací u pacientů s již vyvinutým diabetem.

In English

Extrahepatic manifestations of hepatitis C virus infection (HCV) are very common. A link with the HCV infection is considered to be established with membranoproliferative glomerulonephritis, leukocytoclastic vasculitis, lympho-proliferative disorders (in particular B-cell lymphoma), Sjogren and sicca syndrome, lichen planus, porfyria cuta-nea tarda and diabetes mellitus. Antiviral therapy may prevent progression to diabetes in patients with prediabe-tes who have hepatitis C and may reduce renal and cardiovascular complications in patients with established diabetes who have hepatitis C.